Clinical Trials Browser

Phase 3 × Multiple Myeloma × Surveys and Questionnaires × Clear all

NCT01413178 2020-04-21

A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Phase 3 Completed

205 enrolled 11 charts

Multiple Myeloma, Neoplasms, Plasma Cell